HCC: The role of immunotherapy beyond advanced HCC

December 06, 2023 00:29:42
HCC: The role of immunotherapy beyond advanced HCC
COR2ED - Oncology Medical Conversation
HCC: The role of immunotherapy beyond advanced HCC

Dec 06 2023 | 00:29:42

/

Show Notes

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode

December 06, 2023 00:19:44
Episode Cover

Prostate cancer: Treatment intensification in mCSPC - The nurse perspective

In this podcast GU NURSES CONNECT members Brenda Martone and Jennifer Sutton discuss the nurse role in managing treatment intensification for metastatic castration sensitive...

Listen

Episode

December 06, 2023 00:32:39
Episode Cover

Neuroendocrine tumours: The role of SSA at progression - To continue or not?

In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether to continue or...

Listen

Episode

December 06, 2023 00:12:16
Episode Cover

HCC: Highlights from ASCO and WCGIC 2021

In this episode, Dr Choo discusses some key abstracts presented during the virtual ASCO and WCGIC congresses in 2021. Dr Choo comments that despite...

Listen